Abeona Therapeutics
- Pharmaceutical Preparations
- Cleveland, Ohio
Compensation history
Top executives at Abeona Therapeutics received an average of $1M per person in annual compensation from 2013 to 2023.
Average pay of disclosed executives at Abeona Therapeutics
By year
Executives
We found 13 executives who work or worked at Abeona Therapeutics.
Vishwas Seshadri
Abeona Therapeutics
Chief Executive Officer
Joseph Vazzano
Abeona Therapeutics
Chief Financial Officer
Brendan O'Malley
Abeona Therapeutics
General Counsel
Edward Carr
Abeona Therapeutics
Chief Financial Officer
Michael Amoroso
Abeona Therapeutics
Chief Executive Officer
Steven Rouhandeh
Abeona Therapeutics
Chairman
João Siffert
Abeona Therapeutics
Chief Executive Officer
Christine Silverstein
Abeona Therapeutics
Chief Financial Officer
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
Abeona Therapeutics CEO Michael Amoroso's 2021 pay jumps 104% to $3.1M
July 11, 2022
Abeona Therapeutics CEO João Siffert's 2019 pay jumps 49% to $2.3M
April 10, 2020
Abeona Therapeutics CEO Frank Thiel receives $4.2M in 2018
April 11, 2019
About Abeona Therapeutics
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryPharmaceutical Preparations
- Address6555 Carnegie Ave, 4th Floor, Cleveland, Ohio 44103
- Phone646-813-4701
- Fiscal year endDecember 31
- Former names
- PLASMATECH BIOPHARMACEUTICALS INCUntil June 3, 2015
- ACCESS PHARMACEUTICALS INCUntil August 13, 2014
- CHEMEX PHARMACEUTICALS INCUntil February 4, 1996
Source: SEC filings on November 12, 2024, April 13, 2023, July 11, 2022, April 10, 2020, April 11, 2019, April 9, 2018, April 10, 2017, April 6, 2016, and April 7, 2015.